(Total Views: 244)
Posted On: 03/08/2019 9:25:17 AM
Post# of 72452
edited: I completely disagree. Yes, financing is certainly an issue. But the desperation is no where near as bad as many think and post.
Likely the only funds being utilized are for rent and getting the subsidiary up and running. And if their working with a global BP to make that happen?
Then it's one of those, "checks in the mail". Getting the deal inked and released, that's all we're waiting for imo. One of my other bio's is pretty much broke and still moving forward with their Harvard trial. Just went into recruiting status on the FDA site, they couldn't even afford a PR to shout out about it lol.
I will add that going past 31 March without a partnership/licensing deal will make some pucker up. But I believe they can still survive. Just as I mentioned about my other bio.
Likely the only funds being utilized are for rent and getting the subsidiary up and running. And if their working with a global BP to make that happen?
Then it's one of those, "checks in the mail". Getting the deal inked and released, that's all we're waiting for imo. One of my other bio's is pretty much broke and still moving forward with their Harvard trial. Just went into recruiting status on the FDA site, they couldn't even afford a PR to shout out about it lol.
I will add that going past 31 March without a partnership/licensing deal will make some pucker up. But I believe they can still survive. Just as I mentioned about my other bio.
(1)
(0)
